Christopher W Cairo

Christopher W Cairo

University of Alberta

H-index: 37

North America-Canada

About Christopher W Cairo

Christopher W Cairo, With an exceptional h-index of 37 and a recent h-index of 23 (since 2020), a distinguished researcher at University of Alberta, specializes in the field of medicinal chemistry, glycobiology, carbohydrate chemistry, bioconjugate chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Convergent synthesis of a hexadecavalent heterobifunctional ABO blood group glycoconjugate

Facile synthesis of C5-azido derivatives of thiosialosides and 2, 3-dehydro-5-N-acetylneuraminic acid (DANA)

Secondary deficiency of neuraminidase 1 contributes to CNS pathology in neurological mucopolysaccharidoses via hypersialylation of brain glycoproteins

Bioisosteres at C9 of 2, 3-didehydro-5-N-acetyl neuraminic acid identify selective inhibitors of NEU3

New insights into the glycobiology of immune thrombocytopenia

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption

Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase

NEU1 and NEU3 enzymes alter CD22 organization on B cells

Christopher W Cairo Information

University

Position

Professor Department of Chemistry

Citations(all)

4735

Citations(since 2020)

1722

Cited By

3666

hIndex(all)

37

hIndex(since 2020)

23

i10Index(all)

70

i10Index(since 2020)

52

Email

University Profile Page

University of Alberta

Google Scholar

View Google Scholar Profile

Christopher W Cairo Skills & Research Interests

medicinal chemistry

glycobiology

carbohydrate chemistry

bioconjugate chemistry

Top articles of Christopher W Cairo

Title

Journal

Author(s)

Publication Date

Convergent synthesis of a hexadecavalent heterobifunctional ABO blood group glycoconjugate

Carbohydrate Research

Gour Chand Daskhan

Hanh-Thuc Ton Tran

Christopher W Cairo

2024/1/1

Facile synthesis of C5-azido derivatives of thiosialosides and 2, 3-dehydro-5-N-acetylneuraminic acid (DANA)

Carbohydrate Research

Mostafa Radwan

Manas Jana

Christopher W Cairo

2024/2/1

Secondary deficiency of neuraminidase 1 contributes to CNS pathology in neurological mucopolysaccharidoses via hypersialylation of brain glycoproteins

bioRxiv

Tianmeng Xu

Rachel Héon-Roberts

Travis Moore

Patricia Dubot

Xuefang Pan

...

2024

Bioisosteres at C9 of 2, 3-didehydro-5-N-acetyl neuraminic acid identify selective inhibitors of NEU3

Mostafa Radwan

Christopher Cairo

2023/11/14

New insights into the glycobiology of immune thrombocytopenia

Katherine H Tiemeyer

David J Kuter

Christopher W Cairo

Marie A Hollenhorst

2023/11/1

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption

JCI insight

Ikhui Kho

Ekaterina P Demina

Xuefang Pan

Irene Londono

Christopher W Cairo

...

2023/10/10

Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase

2023/10/3

NEU1 and NEU3 enzymes alter CD22 organization on B cells

Biophysical Reports

Hanh-Thuc Ton Tran

Caishun Li

Radhika Chakraberty

Christopher W Cairo

2022/9/14

Treatment of pulmonary fibrosis using inhibitors of neu1 sialidase

2022/9/8

The Janus‐like role of neuraminidase isoenzymes in inflammation

The FASEB Journal

Md Amran Howlader

Ekaterina P Demina

Suzanne Samarani

Tianlin Guo

Antoine Caillon

...

2022/5

Methods of modulating leukocytes activation and thrombocyte clearance with inhibitors of specific neuraminidase isoenzymes

2022/4/14

Inhibitors of human neuraminidase enzymes block transmigration in vitro

Frontiers in Molecular Biosciences

Md Amran Howlader

Tianlin Guo

Christopher W Cairo

2022/2/25

Profiling of glycosphingolipids with SCDase digestion and HPLC-FLD-MS

Analytical Biochemistry

Radhika Chakraberty

Bela Reiz

Christopher W Cairo

2021/10/15

Limited hydrolysis of polysialic acid by human neuraminidase enzymes

Carmanah D Hunter

Christopher Cairo

2021/2/22

Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low‐Density Lipoproteins and Increasing Their Uptake by Macrophages

Journal of the American Heart Association

Ekaterina P Demina

Victoria Smutova

Xuefang Pan

Anne Fougerat

Tianlin Guo

...

2021/2/16

Therapeutic effect of neuraminidase-1–selective inhibition in mouse models of bleomycin-induced pulmonary inflammation and fibrosis

Journal of Pharmacology and Experimental Therapeutics

Irina G Luzina

Erik P Lillehoj

Virginia Lockatell

Sang W Hyun

Katerina N Lugkey

...

2021/1/1

Characterization of ABH-subtype donor-specific antibodies in ABO-A-incompatible kidney transplantation

American Journal of Transplantation

Andrew Bentall

Mylvaganam Jeyakanthan

Manjit Braitch

Christopher W Cairo

Todd L Lowary

...

2021/11/1

NIST interlaboratory study on glycosylation analysis of monoclonal antibodies: comparison of results from diverse analytical methods

Molecular & Cellular Proteomics

Maria Lorna A De Leoz

David L Duewer

Adam Fung

Lily Liu

Hoi Kei Yau

...

2020/1/1

An Improved, Versatile, and Easily Scalable Synthesis of Sphingomyelins: Application to Stable Isotope Labeling

Synthesis

Nicolas Philippe

Serge Pérard

Franck Le Strat

Jörg Blankenstein

Sébastien Roy

2020/7

Human Neuraminidase Inhibitor-Unique identifiers

Christopher W Cairo

2020/6/1

See List of Professors in Christopher W Cairo University(University of Alberta)

Co-Authors

H-index: 133
Michael Dustin

Michael Dustin

University of Oxford

H-index: 81
Laura L. Kiessling

Laura L. Kiessling

Massachusetts Institute of Technology

H-index: 65
Jillian Buriak

Jillian Buriak

University of Alberta

H-index: 37
Alex Brown

Alex Brown

University of Alberta

H-index: 24
Michele R Richards

Michele R Richards

University of Alberta

academic-engine